118 related articles for article (PubMed ID: 17076976)
1. Asthma control in Switzerland: a general practitioner based survey.
Leuppi JD; Steurer-Stey C; Peter M; Chhajed PN; Wildhaber JH; Spertini F
Curr Med Res Opin; 2006 Nov; 22(11):2159-66. PubMed ID: 17076976
[TBL] [Abstract][Full Text] [Related]
2. Treatment persistence with leukotriene receptor antagonists and inhaled corticosteroids.
Dorais M; Blais L; Chabot I; LeLorier J
J Asthma; 2005 Jun; 42(5):385-93. PubMed ID: 16036414
[TBL] [Abstract][Full Text] [Related]
3. Pharmacogenetic study of the effects of NK2R G231E G>A and TBX21 H33Q C>G polymorphisms on asthma control with inhaled corticosteroid treatment.
Ye YM; Lee HY; Kim SH; Jee YK; Lee SK; Lee SH; Park HS
J Clin Pharm Ther; 2009 Dec; 34(6):693-701. PubMed ID: 20175803
[TBL] [Abstract][Full Text] [Related]
4. Tolerability profiles of leukotriene receptor antagonists and long-acting beta2-adrenoceptor agonists in combination with inhaled corticosteroids for treatment of asthma: a review.
Colucci R; Fornai M; Tuccori M; Antonioli L; Pasqualetti G; Blandizzi C; Del Tacca M
J Asthma; 2007; 44(6):411-22. PubMed ID: 17654125
[TBL] [Abstract][Full Text] [Related]
5. Phenotypic determinants of uncontrolled asthma.
Siroux V; Boudier A; Bousquet J; Bresson JL; Cracowski JL; Ferran J; Gormand F; Just J; Le Moual N; Morange S; Nadif R; Oryszczyn MP; Pison C; Scheinmann P; Varraso R; Vervloet D; Pin I; Kauffmann F;
J Allergy Clin Immunol; 2009 Oct; 124(4):681-7.e3. PubMed ID: 19665764
[TBL] [Abstract][Full Text] [Related]
6. Factors associated with the control of severe asthma.
Hermosa JL; Sánchez CB; Rubio MC; Mínguez MM; Walther JL
J Asthma; 2010 Mar; 47(2):124-30. PubMed ID: 20170317
[TBL] [Abstract][Full Text] [Related]
7. Appropriate use of inhaled corticosteroid and long-acting beta(2)-adrenergic agonist combination therapy among asthma patients in a US commercially insured population.
Ye X; Gutierrez B; Zarotsky V; Nelson M; Blanchette CM
Curr Med Res Opin; 2009 Sep; 25(9):2251-8. PubMed ID: 19622006
[TBL] [Abstract][Full Text] [Related]
8. Predictors of asthma control in everyday clinical practice in Switzerland.
Taegtmeyer AB; Steurer-Stey C; Price DB; Wildhaber JH; Spertini F; Leuppi JD
Curr Med Res Opin; 2009 Oct; 25(10):2549-55. PubMed ID: 19735165
[TBL] [Abstract][Full Text] [Related]
9. Disease control in asthmatic children seen in private practice in Switzerland.
Moeller A; Steurer-Stey C; Suter H; Hofer M; Peter M; Brooks-Wildhaber J; Hammer J; Wildhaber JH
Curr Med Res Opin; 2006 Jul; 22(7):1295-306. PubMed ID: 16834828
[TBL] [Abstract][Full Text] [Related]
10. Identifying 'well-controlled' and 'not well-controlled' asthma using the Asthma Control Questionnaire.
Juniper EF; Bousquet J; Abetz L; Bateman ED;
Respir Med; 2006 Apr; 100(4):616-21. PubMed ID: 16226443
[TBL] [Abstract][Full Text] [Related]
11. Can the Asthma Control Questionnaire be used to differentiate between patients with controlled and uncontrolled asthma symptoms? A pilot study.
van den Nieuwenhof L; Schermer T; Eysink P; Halet E; van Weel C; Bindels P; Bottema B
Fam Pract; 2006 Dec; 23(6):674-81. PubMed ID: 16880177
[TBL] [Abstract][Full Text] [Related]
12. Evidence-based pharmacologic treatment for mild asthma.
Koh MS; Irving LB
Int J Clin Pract; 2007 Aug; 61(8):1375-9. PubMed ID: 17590220
[TBL] [Abstract][Full Text] [Related]
13. Asthma control: do patients' and physicians' opinions fit in with patients' asthma control status?
Prieto L; Badiola C; Villa JR; Plaza V; Molina J; Cimas E
J Asthma; 2007; 44(6):461-7. PubMed ID: 17654133
[TBL] [Abstract][Full Text] [Related]
14. [Investigation of optimal drug in moderate bronchial asthma].
Kataoka A; Nishimura N; Uchiyama N; Ono H; Kishi J; Chonabayashi N
Arerugi; 2007 Jul; 56(7):685-90. PubMed ID: 17671411
[TBL] [Abstract][Full Text] [Related]
15. A 12-week, multicenter, randomized, partially blinded, active-controlled, parallel-group study of budesonide inhalation suspension in adolescents and adults with moderate to severe persistent asthma previously receiving inhaled corticosteroids with a metered-dose or dry powder inhaler.
Murphy K; Noonan M; Silkoff PE; Uryniak T
Clin Ther; 2007 Jun; 29(6):1013-26. PubMed ID: 17692718
[TBL] [Abstract][Full Text] [Related]
16. Inhaled corticosteroids vs. leukotriene-receptor antagonists and asthma exacerbations in children.
Blais L; Kettani FZ; Lemière C; Beauchesne MF; Perreault S; Elftouh N; Ducharme FM
Respir Med; 2011 Jun; 105(6):846-55. PubMed ID: 21196105
[TBL] [Abstract][Full Text] [Related]
17. Status of inhalation therapy in bronchial asthma in adults above twelve years of age in armed forces.
Barthwal MS; Deoskar RB; Rajan KE
J Assoc Physicians India; 2005 Aug; 53():681-4. PubMed ID: 16398075
[TBL] [Abstract][Full Text] [Related]
18. The anti-inflammatory effects of inhaled corticosteroids versus anti-leukotrienes on the lymphocyte P-glycoprotein (PGP) expression in asthmatic children.
Kopriva F; Dzubak P; Potesil J; Hajduch M
J Asthma; 2009 May; 46(4):366-70. PubMed ID: 19484671
[TBL] [Abstract][Full Text] [Related]
19. Resource utilization in asthma: combined fluticasone propionate/salmeterol compared with inhaled corticosteroids.
Friedman HS; Yawn BP
Curr Med Res Opin; 2007 Feb; 23(2):427-34. PubMed ID: 17288696
[TBL] [Abstract][Full Text] [Related]
20. Factors associated with asthma control.
de Vries MP; van den Bemt L; Lince S; Muris JW; Thoonen BP; van Schayck CP
J Asthma; 2005 Oct; 42(8):659-65. PubMed ID: 16266957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
